RemeGen Co., Ltd. (688331)
SSE
Closed
Sep 18, 2026
Day's Range
114.6152 wk Range
75.03Overview - 688331 - RemeGen Co., Ltd.
Key Statistics
Valuation
Enterprise Value
58.86B
P/E (Trailing)
‪10.98‬
P/E (Forward)
‪81.07‬
PEG Ratio
‪81.07‬
Price / Sales (TTM)
‪8.08‬
Price / Book
‪7.66‬
EV / EBITDA
‪11.44‬
Profitability
Profit Margin
‪72.71%‬
Operating Margin
‪84.45%‬
Return on Assets
‪39.01%‬
Return on Equity
‪109.10%‬
Ownership
Shares Outstanding
563.71M
Float
341.21M
Held by Insiders
‪56.87%‬
Held by Institutions
‪13.58%‬
Price stats
Beta
‪0.45‬
50-Day Avg
‪125.64‬
200-Day Avg
‪113.95‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
7 analysts
Average price target
‪CN¥ 146.22‬Market Cap - 688331 - RemeGen Co., Ltd.
Peers - 688331 - RemeGen Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on SSE.
- 688331SSERemeGen Co., Ltd.64.73BMarket Cap+8.05%52-week change10.99P/E (Trailing)‪72.71%‬Profit Margin
- 688235SSEBeigene Ltd.363.67BMarket Cap-29.40%52-week change85.57P/E (Trailing)‪10.69%‬Profit Margin
- 688796SSEBiocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares53.41BMarket Cap+45.35%52-week change145.83P/E (Trailing)‪21.55%‬Profit Margin
- 688428SSEInnoCare Pharma Ltd.46.51BMarket Cap-4.22%52-week change54.78P/E (Trailing)‪33.04%‬Profit Margin
- 688578SSEShanghai Allist Pharmaceuticals Co., Ltd.44.77BMarket Cap-12.78%52-week change16.75P/E (Trailing)‪43.67%‬Profit Margin
- 688336SSESunshine Guojian Pharmaceutical Co., Ltd.34.11BMarket Cap+0.89%52-week change11.10P/E (Trailing)‪69.64%‬Profit Margin
- 603392SSEBeijing Wantai Biological Pharmacy Enterprise Co., Ltd.33.22BMarket Cap-124.77%52-week change826.25P/E (Trailing)‪-18.90%‬Profit Margin
Profile Summary - 688331 - RemeGen Co., Ltd.
About
RemeGen Co., Ltd. is a biotechnology company focusing on the research, development, and commercialization of novel biologics for the treatment of cancer, autoimmune disorders, and other serious diseases. As a pioneering entity in the biotech industry, RemeGen concentrates on creating innovative protein drugs and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
